福他替尼是R406的活性代谢物的原药,是Syk抑制剂,IC50为41 nM,是美国食品和药物管理局自2018年以来批准的用于治疗慢性免疫性血小板减少症(ITP)的药物。该药物作为六水合二钠盐口服给药,并且是活性化合物他马替尼(R-406)的前药,该活性化合物是脾酪氨酸激酶(Syk)的抑制剂,因此它是syk抑制剂。

清空选项
24313-88-0 3,4,5-Trimethoxyaniline
BD8156724313-88-098%
¥29.005g常备现货
841290-80-0 6-[5-Fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one
BD208780841290-80-098%
¥129.00100mg常备现货
901119-35-5 (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl dihydrogen phosphate
BD304660901119-35-598%
¥2100.00100mg常备现货
229625-50-7 Di-tert-butyl chloromethyl phosphate
BD222347229625-50-795%
¥520.0025g常备现货
914295-16-2 Sodium (6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl phosphate hexahydrate
BD306048914295-16-298%
¥2400.00250mg常备现货
575484-83-2 6-((2-Chloro-5-fluoropyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one
BD262185575484-83-295+%
¥5999.0025g
1